Navigation Links
PhRMA Statement on AARP-White House Press Conference

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin today issued the following statement regarding today's AARP-White House press conference on health care reform:

"With the strong support of AARP, we believe this agreement will be looked back in time as a momentum changer in the legislative efforts to reform our troubled health care system. Our $80 billion pledge toward that goal represents a huge financial commitment by America's pharmaceutical research and biotechnology companies. But we have a shared vision: every single person in America, regardless of their income, should have access to affordable, high-quality health care coverage and services.

"Even though we have had policy disagreements in the past, this is an historic coming-together moment. AARP, the largest advocacy organization on behalf of American seniors, clearly recognizes the importance of innovative, cutting-edge medicines to the lives of patients everywhere.

"And we recognize that a medicine which sits on a shelf out of reach of patients financially doesn't do anyone any good. Working together with President Obama, Senate Finance Committee Chairman Baucus and other congressional leaders, we have now taken an important first step toward achieving comprehensive health care reform this year.

"In life, we get precious few opportunities to fundamentally improve the lives of people all across our great nation. We are proud to join AARP, the White House and Congress in seizing that moment today."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address:

For information on stories of hope and survival, visit:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit

For information on the danger of imported drugs, visit:

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. EMD Serono to Adopt Revised and Strengthened PhRMA Code
2. Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
3. PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage
4. VaxGen Files 2006 Financial Statements and Provides Cash Update
5. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
6. Anacor Files Registration Statement for Initial Public Offering
7. IsoTis Files Definitive Proxy Statement
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. Statement on Direct-To-Consumer Genetic Testing
10. Coherent Announces Restatement Related to Stock-Based Compensation
11. XTL Biopharmaceuticals: AGM/EGM Statements
Post Your Comments:
(Date:10/13/2015)... -- the United States , ... about 14% of all new cases of kidney cancer.   ... and Europe .  PRCC represents about ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that ... (publ) ("AstraZeneca") have completed enrolment in a global Phase II study ...
(Date:10/12/2015)... 2015  Rebiotix Inc. today announced that U.S. ... lead Microbiota Restoration Therapy (MRT) RBX2660 as a ... Clostridium difficile (C diff) infection, a challenging ... deaths in the U.S. annually. 1 Rebiotix ... founded to revolutionize the treatment of debilitating GI ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... ... October 12, 2015 , ... LifeTrak , a leader in consumer ... the world’s first amphibious fitness tracker that seeks to meet the needs of multi-sport ... heart rate monitoring both in water and on land, making it the ...
Breaking Biology Technology:
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
(Date:9/26/2015)... 26th, 2015  Results of a TactioRPM pilot ... today at the Stanford Medicine X Conference. In ... Dashboards, Connected Health Devices and Pharmacogenomics", Roger ... will explain how senior patients equipped with connected ... pharmacist via the TactioRPM remote patient monitoring platform ...
(Date:9/10/2015)... , Sept. 10, 2015 Report ... New Study Reveals Selling Opportunities and Revenue Prospects ... the future of biologics, especially new drug classes? ... will stay ahead with exclusive market data and ... explore trends, developments, results, opportunities and sales predictions. ...
Breaking Biology News(10 mins):